DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Venture Capital Intelligence at $199 a month for every name. Every figure, date and source on this page is public either way.
Companies / E••••••• I•••
E••••••• I•••
Stage unknownPhiladelphia, PAPharmaceuticals
Facts
- Year of incorporation
- unknown
- Revenue range (Form D)
- Decline to Disclosesec.gov
- Rounds on record
- 1
- Disclosed raised
- unknownsum of rounds with a disclosed amount only
- Named investors
- 0
Financing history
1 rounds
- Jan 8, 2024Form D equity offering · $125,000 (form d sold) · 3 investorsFact Form D · “••• Locked”
Investors on record
0 edges
No named investor yet.
People
1 officers, 2 directors
- T••••• K•• Executive Officer/Director sec.gov
- E••• S••••••••• Director Fact
- Y••••• C••• Director Fact
Timeline
1
- Jan 16, 2024••• LockedForm D filed Fact Form D
Evidence
14 observations
Every observation on this company
- Entity type: Corporation Jan 16, 2024 Fact Form D
- Form D industry group: Pharmaceuticals Jan 16, 2024 Fact Form D
- Amendment: false Jan 16, 2024 Fact Form D
- Revenue range (Form D): Decline to Disclose Jan 16, 2024 Fact Form D
- Incorporated: overFiveYears Jan 16, 2024 Fact Form D
- Jurisdiction: Delaware Jan 16, 2024 Fact Form D
- Amount sold (Form D): $125,000 Jan 16, 2024 Fact Form D
- Offering amount (Form D): $1.5M Jan 16, 2024 Fact Form D
- Exemptions: 06b Jan 16, 2024 Fact Form D
- First sale: 2024-01-08 Jan 16, 2024 Fact Form D
- Investors (Form D): 3 Jan 16, 2024 Fact Form D
- Minimum investment (Form D): 25,000 Jan 16, 2024 Fact Form D
- Securities offered: debt,option Jan 16, 2024 Fact Form D
- Office address: ••• Locked Jan 16, 2024 Fact Form D